An assay that uses machine-learning algorithms on phenotypic-biomarker data from live primary cells predicts post-surgical adverse pathology in prostate-cancer and breast cancer tissue samples from patients.
- Michael S. Manak
- Jonathan S. Varsanik
- Ashok C. Chander